UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
___________________________________________________________________
Date of Report (Date of earliest event reported): March 2, 2011
Biozone Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
| |
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
| |
|
|
|
4400 Biscayne Blvd
Suite 800
Miami, FL
|
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Registrant’s telephone number, including area code: (800) 689-0930
| |
|
(Former name or former address, if changed since last report)
|
| |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On March 2, 2011, Biozone Pharmaceuticals, Inc. (f/k/a International Surf Resorts, Inc.) (the “Company”) issued a press release announcing that it entered into a binding option and letter of intent to purchase BioZone Laboratories, Inc. and its related companies.
The press release also announced the Company’s name change from “International Surf Resorts, Inc.” to "Biozone Pharmaceuticals, Inc." and its implementation of a ten-for-one forward stock split, as previously described in our Current Report on Form 8-K filed with the Securities and Exchange Commission on March 4, 2011.
A copy of the press release is attached hereto as Exhibit 99.1
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated March 2, 2011
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
Date: March 4, 2011
|
|
|
|
|
|
|
| |
|
BIOZONE LABORATORIES, INC.
|
|
| |
|
By:
|
Roberto Prego Novo
|
|
|
|
| |
|
Name:
|
Roberto Prego Novo
|
|
|
| |
|
Title:
|
President
|
|
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated March 2, 2011
|